Company
ARS Pharma
The FIRST & ONLY Needle-Free Epinephrine
Also known as ARS Pharmaceuticals, Inc.
- Customers
- patients and caregivers
- Legal name
- ARS Pharmaceuticals, Inc.
- ars-pharma.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
ARS Pharmaceuticals is dedicated to transforming the treatment of severe allergic reactions. Our mission is to develop innovative, patient-friendly and easy-to-use treatments that empower people with allergies and their caregivers to treat at the first sign of symptoms.
Funding snapshot
- Total raised
- $63MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $55M2021-08-26
Funding rounds
- Round, 2021
- $55M2021-08-26, SEC form D sold, 8 investors
- Round, 2018
- $8M2018-09-14, SEC form D sold, 2 investors
Products
- Other
- neffy
- Web
- neffy
Loading relationship preview